Stocktoria
MADRIGAL PHARMACEUTICALS, INC. MDGL
MADRIGAL PHARMACEUTICALS, INC. statistics & valuation
Market cap$11.8B
P / S12.3×
P / B19.6×
Net margin-30.1%
Return on equity-47.8%
FCF margin-19.8%
Net debt$141.2M
Enterprise value USD$12.0B
Earnings yield EBIT/EV-2.5%
Return on capital-31.6%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -31.3% | -276.4% | — | — | — | — | — | — | — | — |
| Net margin | -30.1% | -258.6% | — | — | — | — | — | — | — | — |
| FCF margin | -19.8% | -253.7% | — | — | — | — | — | — | — | — |
| Return on assets | -22.9% | -44.7% | -58.3% | -81.5% | -88.5% | -70.5% | -19.0% | -6.8% | -16.2% | -64.0% |
| Return on equity | -47.8% | -61.8% | -92.2% | -149.6% | -123.3% | -84.3% | -20.2% | -6.9% | -17.1% | -72.5% |
| Debt / equity | 0.56× | 0.16× | 0.28× | 0.35× | 0.00× | — | — | — | — | — |
| Current ratio | 4.01 | 6.10 | 5.38 | 3.12 | 3.54 | 6.13 | 17.52 | 57.46 | 19.10 | 8.58 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.